John McMullen
Analyst · Loop Capital. Please go ahead
Thanks, VJ. Good afternoon, everyone. For the first quarter, we reported revenue of $152 million, a decrease of 8% compared to the first quarter of 2018, including a 3% negative impact from foreign currency. GAAP gross profit margin was 43.2% compared to 46.9% in the first quarter of 2018. GAAP operating expenses decreased 9% to $87 million. We reported a GAAP loss of $0.22 per share in the first quarter of 2019 compared to a loss of $0.19 per share in 2018. We reported a non-GAAP loss of $0.09 per share or $10.1 million in the first quarter of 2019 compared to a non-GAAP loss of $0.03 per share or $3.4 million in the first quarter of 2018. While we expect headwinds from the timing of the large enterprise customers' orders throughout the year, we believe our growth drivers and opportunities remain unchanged. We continue to expect printers, materials, healthcare and software to fuel long-term growth. During the first quarter, printer unit sales increased 90%, but as a result of mix of unit selling prices, credit revenue decreased 29% to $28 million, primarily driven by timing of orders of a large enterprise customer. Printer unit sales, revenue mix and overall average selling price will likely continue to fluctuate specifically as we ramp sales with new products at a wide range of prices from $5,000 to over $1 million. Materials revenue decreased 3% to $41.4 million in the first quarter. A lag time of two to three quarters between printer unit sale and scaling materials utilization is typical. As we discussed last quarter, we are also experiencing a decline in legacy materials at a faster rate than materials related to core and new systems are accelerated. We believe those trends begin to cross this year, and we continue to expect materials growth rates to improve in the second half of 2019. Healthcare services and simulation revenue increased, but the impact of the large customer orders' timing offset those increases, and total healthcare revenue decreased 5% to $50 million. Excluding the larger enterprise customers orders from each year, healthcare revenues increased approximately 18%. We continue to be pleased with the overall demand trends for healthcare, including our NextDent 5100 3D printer. Software revenue decreased 8% to $20.8 million in the first quarter, primarily as a result of lower Cimatron product revenue. While quarterly performance may fluctuate, we continue to expect growth from software long term and are taking actions to improve software growth rates and enhance our software portfolio. On-demand services revenue decreased 12% to $22.6 million in the quarter. We expected headwinds through the second quarter related to the business adjustments, related to export compliance and outsourcing. And we experienced additional weakness from automotive customers in Europe in the first quarter. We reported GAAP gross profit margin of 43.2% in the first quarter of 2019, a decrease of 370 basis points driven by under absorption of supply chain overhead related to lower revenue and production during the quarter, as well as the impact of mix of sales within categories. Non-GAAP gross profit margin in the first quarter of 2019 was 44.2% compared to 47.1% last year. We continue to drive supply chain optimization, manufacturing efficiencies and process improvements, but with inventory reduction actions and lower production at our manufacturing facilities, we expect gross profit margins in the mid-40s of the balance of the year. GAAP operating expenses for the quarter were $87 million, a decrease of 9% compared to the first quarter of 2018, including a 6% decrease in SG&A expenses and a 15% decrease in R&D expenses. Non-GAAP operating expenses in the first quarter were $72.9 million, an 8% decrease from the first quarter of the prior year and a 4% decrease sequentially. Compared to the 2018 quarter, non-GAAP SG&A expenses decreased 5% to $51 million with lower compensation costs, bad debt commissions and building expenses partially offset by higher legal fees. Non-GAAP R&D expenses decreased 15% to $21.9 million, as a result of lower compensation costs and R&D materials as we focus development on materials from software this year. We believe we are beyond the phase of heavy investments we needed to begin to turn the Company around and are focused on reducing costs this year and driving profitability. We used $15.2 million of cash in operations during the first quarter. We ended the quarter with $157.3 million of unrestricted cash on hand. The use of cash during the quarter was driven by the impact of lower-than-anticipated results and higher inventory. While cash use and generation will continue to fluctuate from period-to-period, we expect to generate organic free cash flow in 2019 as we significantly reduce inventory through the end of the year and reduce capital expenditures compared to the prior year. With that, I'll turn the call back to VJ. VJ?